Clinical Nurse Specialist in Grand Junction, CO Accepting Medicare
6 Clinical Nurse Specialist nurses found. Showing 1 - 6
 Ms. Leslie Jane Schiller, RN MS CS Clinical Nurse Specialist - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 951 Main St, Grand Junction, CO 81501 Phone: 970-242-4567 Fax: 970-248-9006 |
Teri Lee Leishman, APP AG-CNS Clinical Nurse Specialist - Perioperative Medicare: Medicare Enrolled Practice Location: 2108 Monument Village Cir, Grand Junction, CO 81507 Phone: 801-645-1175 |
Emily L Cohu, APN-CNS Clinical Nurse Specialist - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 2330 Wren Ct, Grand Junction, CO 81507 Phone: 970-631-7411 |
Bonnie Souser, CNS Clinical Nurse Specialist - Oncology Medicare: Accepting Medicare Assignments Practice Location: 2635 N 7th St, Grand Junction, CO 81501 Phone: 970-298-2273 |
Mrs. Frances Wilson Higgins, RN MS CS Clinical Nurse Specialist - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 951 Main St, Grand Junction, CO 81501 Phone: 970-242-4567 Fax: 970-248-9006 |
Carrie Shahbahrami, MSN,RXN,CNS,ACCNS-AG Clinical Nurse Specialist - Acute Care Medicare: Accepting Medicare Assignments Practice Location: 1006 N 5th St, Grand Junction, CO 81501 Phone: 970-579-0003 Fax: 970-433-7671 |
News Archive
Events of 2020 moved medical students to political activism
Inam Sakinah and her classmates will forever be known as the students who started medical school during the 2020 Covid-19 pandemic.
LEDGF protein controls the location of HIV integration in human cells
A human DNA-associated protein called LEDGF is the first such molecule found to control the location of HIV integration in human cells, according to researchers at the University of Pennsylvania School of Medicine.
NIH $1 million Challenge Grant to refine cell-tracking nanotube technology
The National Institutes of Health (NIH) has awarded researchers at Rice University and the Texas Heart® Institute (THI) a $1 million Challenge Grant to refine cell-tracking nanotube technology that could make magnetic resonance imaging (MRI) up to 40 times more sensitive than existing MRIs and help guide adult stem cells within the human body to repair damaged hearts.
Pivotal Therapeutics reports net loss of $1.2 million for first quarter 2015
Pivotal Therapeutics Inc., a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the three months ended March 31, 2015.
Acucela, Otsuka Pharmaceutical granted FDA Fast Track designation for ACU-4429 in treatment of dry AMD
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
› Verified 2 days ago